{"name":"BioCryst Pharmaceuticals","permalink":"biocryst-pharmaceuticals","crunchbase_url":"http://www.crunchbase.com/company/biocryst-pharmaceuticals","homepage_url":"http://www.biocryst.com","blog_url":"","blog_feed_url":"","twitter_username":"","category_code":"biotech","number_of_employees":null,"founded_year":null,"founded_month":null,"founded_day":null,"deadpooled_year":null,"deadpooled_month":null,"deadpooled_day":null,"deadpooled_url":null,"tag_list":"","alias_list":"","email_address":"info@biocryst.com","phone_number":"205-444-4600","description":"","created_at":"Sat Feb 26 07:36:37 UTC 2011","updated_at":"Sat Feb 26 07:42:20 UTC 2011","overview":"<p>BioCryst has over 80 employees spread across their two locations in Birmingham, Alabama and Durham, North Carolina. With expertise in drug discovery, clinical development and regulatory affairs, they continue to advance their compounds, peramivir, forodesine and BCX4208, and to generate new compounds from their own discovery engineâ€”structure-based drug design.</p>","image":{"available_sizes":[[[150,51],"assets/images/resized/0012/4081/124081v1-max-150x150.jpg"],[[191,66],"assets/images/resized/0012/4081/124081v1-max-250x250.jpg"],[[191,66],"assets/images/resized/0012/4081/124081v1-max-450x450.jpg"]],"attribution":null},"products":[],"relationships":[],"competitions":[],"providerships":[],"total_money_raised":"$0","funding_rounds":[],"investments":[],"acquisition":null,"acquisitions":[],"offices":[{"description":"","address1":"2190 Parkway Lake Drive","address2":"","zip_code":"35244","city":"Birmingham","state_code":"AL","country_code":"USA","latitude":null,"longitude":null}],"milestones":[{"description":"Biocryst Pharmaceuticals (BCRX) Awarded Additional $55.0 Million by the Department of Health and Human Services to Complete Pera","stoned_year":2011,"stoned_month":2,"stoned_day":25,"source_url":"http://www.fiercebiotech.com/press-releases/biocryst-pharmaceuticals-bcrx-awarded-additional-550-million-department-hea","source_text":"","source_description":"Biocryst Pharmaceuticals (BCRX) Awarded Additional $55.0 Million by the Department of Health and Human Services to Complete Pera","stoneable_type":"Company","stoned_value":null,"stoned_value_type":null,"stoned_acquirer":null,"stoneable":{"name":"BioCryst Pharmaceuticals","permalink":"biocryst-pharmaceuticals"}}],"ipo":null,"video_embeds":[],"screenshots":[{"available_sizes":[[[150,124],"assets/images/resized/0012/4082/124082v1-max-150x150.jpg"],[[250,208],"assets/images/resized/0012/4082/124082v1-max-250x250.jpg"],[[450,374],"assets/images/resized/0012/4082/124082v1-max-450x450.jpg"]],"attribution":null}],"external_links":[]}